✦ LIBER ✦

A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: A Gynecologic Oncology Group Study

✍ Scribed by Robert S. Mannel; Mark F. Brady; Elise C. Kohn; Parviz Hanjani; Masamichi Hiura; Roger Lee; Koen DeGeest; David E. Cohn; Bradley J. Monk; Helen Michael

Book ID: 113963170
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 371 KB
Volume: 122
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.03.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase III trial of three vers

Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group study

✍ Jeffrey Bell; Mark F. Brady; Robert C. Young; Janice Lage; Joan L. Walker; Kathe 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 522 KB

Re: “Randomized phase III trial of three

Re: “Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group study”

✍ Maurie Markman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 388 KB

Phase II trial of single agent carboplat

Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and peritoneal cancers: a Southwest Oncology Group trial

✍ Maurie Markman; Tracy Glass; Harriet O Smith; Kenneth D Hatch; Geoffrey R Weiss; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Response to Dr. Markman's letter “Re: ‘R

Response to Dr. Markman's letter “Re: ‘Randomized phase III trial of three versus six cycles of carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group Study’”

✍ Jeffrey Bell 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 46 KB

A phase I trial of dose-dense (biweekly)

A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: A feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: A Gynecologic Oncology Group study

✍ Amy D. Tiersten; Michael W. Sill; Danielle Knight; Franco Muggia; Agustin A. Gar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Induction Pemetrexed and Cisplatin Follo

Induction Pemetrexed and Cisplatin Followed by Maintenance Pemetrexed Versus Carboplatin Plus Paclitaxel Plus Bevacizumab Followed by Maintenance Bevacizumab: A Quality of Life–Oriented Randomized Phase III Study in Patients With Advanced Non-Squamous Non–Small-Cell Lung Cancer (ERACLE)

✍ Domenico Galetta; Salvatore Pisconti; Saverio Cinieri; Giovanni Luigi Pappagallo 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 235 KB